GRCE
Grace Therapeutics, Inc. · Healthcare
Opaleye Management Inc. bought $32K of Grace Therapeutics, Inc.
10% owner
Bought$31,687
$2.10Price
15,089Shares
+1%Stake
What GRCE did for a copier
- $1,000 copied at Fri, Oct 2 open, $2.04
- $966
- S&P 500, same days
- +0.3%
13 of 30 trading days so far, to the Oct 21 close.
Opaleye Management Inc.'s record
63 other buys with 3 months of prices since 2016: on average +20.3% against the S&P 500, and 33 of 63 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Sep 21. Filed Thu, Oct 1, 4:05 PM ET, after the close. Returns use the Oct 2 open and the Oct 21 close. Not investment advice.